Stock Track | Duality Biotherapeutics Soars 5% Intraday as Analysts Boost Estimates After Earnings Report

Stock Track

03/27

Duality Biotherapeutics (HKG:09606) saw its stock price soar 5.00% during intraday trading on Friday, following the release of its annual results and subsequent analyst updates.

The biotech company's shares rallied after analysts boosted their estimates for the company's future performance. According to earnings reports, Duality Biotherapeutics' revenue of CN¥1.9 billion beat expectations by 13%, leading analysts to upgrade their revenue forecasts for 2026 while also reducing their loss estimates.

Despite reporting statutory losses of CN¥39.80 per share in the latest results, analysts now predict losses will shrink substantially by 82% to CN¥5.27 per share in 2026. The positive revision in analyst sentiment appears to have driven investor confidence in the stock during the trading session.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1178986582"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1178986582\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1178986582?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 10:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1178986582","market":"hk","top_or_hot":-1,"title":"Stock Track | Duality Biotherapeutics Soars 5% Intraday as Analysts Boost Estimates After Earnings Report","media":"Stock Track","content":"<p>Duality Biotherapeutics (HKG:09606) saw its stock price soar 5.00% during intraday trading on Friday, following the release of its annual results and subsequent analyst updates.</p><p>The biotech company's shares rallied after analysts boosted their estimates for the company's future performance. According to earnings reports, Duality Biotherapeutics' revenue of CN¥1.9 billion beat expectations by 13%, leading analysts to upgrade their revenue forecasts for 2026 while also reducing their loss estimates.</p><p>Despite reporting statutory losses of CN¥39.80 per share in the latest results, analysts now predict losses will shrink substantially by 82% to CN¥5.27 per share in 2026. The positive revision in analyst sentiment appears to have driven investor confidence in the stock during the trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Duality Biotherapeutics Soars 5% Intraday as Analysts Boost Estimates After Earnings Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Duality Biotherapeutics Soars 5% Intraday as Analysts Boost Estimates After Earnings Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-27 10:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Duality Biotherapeutics (HKG:09606) saw its stock price soar 5.00% during intraday trading on Friday, following the release of its annual results and subsequent analyst updates.</p><p>The biotech company's shares rallied after analysts boosted their estimates for the company's future performance. According to earnings reports, Duality Biotherapeutics' revenue of CN¥1.9 billion beat expectations by 13%, leading analysts to upgrade their revenue forecasts for 2026 while also reducing their loss estimates.</p><p>Despite reporting statutory losses of CN¥39.80 per share in the latest results, analysts now predict losses will shrink substantially by 82% to CN¥5.27 per share in 2026. The positive revision in analyst sentiment appears to have driven investor confidence in the stock during the trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09606","symbol_name":"映恩生物-B","start_time":0,"source_url":"","article_id":"1178986582","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1178986582","pubTimestamp":1774577840,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Duality Biotherapeutics (HKG:09606) saw its stock price soar 5.00% during intraday trading on Friday, following the release of its annual results and subsequent analyst updates.The biotech company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09606":"映恩生物-B"},"translate_title":"个股追踪|Duality Biotherapeutics盘中飙升5%，财报发布后分析师上调预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09606":1},"content_text":"Duality Biotherapeutics (HKG:09606) saw its stock price soar 5.00% during intraday trading on Friday, following the release of its annual results and subsequent analyst updates.The biotech company's shares rallied after analysts boosted their estimates for the company's future performance. According to earnings reports, Duality Biotherapeutics' revenue of CN¥1.9 billion beat expectations by 13%, leading analysts to upgrade their revenue forecasts for 2026 while also reducing their loss estimates.Despite reporting statutory losses of CN¥39.80 per share in the latest results, analysts now predict losses will shrink substantially by 82% to CN¥5.27 per share in 2026. The positive revision in analyst sentiment appears to have driven investor confidence in the stock during the trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}